News

The Impact Journals news page hosts content about important news articles and press releases from our Journals and Editorial Board Members.

News

Mission
The Impact Journals news page hosts articles about important news stories from our journals and within the scientific community. Visit this page for the latest in medical advances, pharmaceutical progress, conference reports, and more.

Oncoscience | Rapamycin in the context of Pascal’s Wager: generative pre-trained transformer perspective

News

December 27, 2022
PRESS RELEASE: On December 21, 2022, a new research perspective was published in Oncoscience, entitled, “Rapamycin in the context of Pascal’s Wager: generative pre-trained transformer perspective.” continue reading »

Oncotarget | Plasma growth hormone is a potential biomarker of response to atezolizumab and bevacizumab in advanced hepatocellular carcinoma patients

Oncotarget

December 22, 2022
PRESS RELEASE: A new research paper was published in Oncotarget, entitled, “Plasma growth hormone is a potential biomarker of response to atezolizumab and bevacizumab in advanced hepatocellular carcinoma patients.” continue reading »

Aging | White matter hyperintensity load is associated with premature brain aging

Aging

December 22, 2022
PRESS RELEASE: A new research paper was published in Aging's Volume 14, Issue 23, entitled, “White matter hyperintensity load is associated with premature brain aging.” continue reading »

Aging | DNA methylation GrimAge version 2

Aging

December 21, 2022
PRESS RELEASE: A new research paper was published in Aging's Volume 14, Issue 23, entitled, “DNA methylation GrimAge version 2.” continue reading »

Genes & Cancer | Systems biology network reveals the correlation between COX-2 expression and Ch 7q copy number alterations in Ch 11q-deleted pediatric neuroblastoma tumors

Genes & Cancer

December 16, 2022
PRESS RELEASE: On December 2, 2022, a new research paper was published in Genes & Cancer, entitled, “Systems biology network reveals the correlation between COX-2 expression and Ch 7q copy number alterations in Ch 11q-deleted pediatric neuroblastoma tumors.” continue reading »